Mukherjee S - Search Results

1

Revisiting Luteolin Against the Mediators of Human Metastatic Colorectal Carcinoma: A Biomolecular Approach.

Chakraborty A, Midde A, Chakraborty P, Adhikary S, Kumar S, Arri N, Chandra Das N, Sen Gupta PS, Banerjee A, Mukherjee S. Chakraborty A, et al. Among authors: mukherjee s. J Cell Biochem. 2024 Sep 20:e30654. doi: 10.1002/jcb.30654. Online ahead of print. J Cell Biochem. 2024. PMID: 39300917

2

Targeting human TLRs to combat COVID-19: A solution?

Patra R, Chandra Das N, Mukherjee S. Patra R, et al. Among authors: mukherjee s. J Med Virol. 2021 Feb;93(2):615-617. doi: 10.1002/jmv.26387. Epub 2020 Aug 13. J Med Virol. 2021. PMID: 32749702 Free PMC article. No abstract available.

3

Cell Surface Fibroblast Activation Protein-2 (Fap2) of Fusobacterium nucleatum as a Vaccine Candidate for Therapeutic Intervention of Human Colorectal Cancer: An Immunoinformatics Approach.

Padma S, Patra R, Sen Gupta PS, Panda SK, Rana MK, Mukherjee S. Padma S, et al. Among authors: mukherjee s. Vaccines (Basel). 2023 Feb 23;11(3):525. doi: 10.3390/vaccines11030525. Vaccines (Basel). 2023. PMID: 36992108 Free PMC article.

4

Immunoinformatics Approaches in Designing Vaccines Against COVID-19.

Chakraborty A, Bayry J, Mukherjee S. Chakraborty A, et al. Among authors: mukherjee s. Methods Mol Biol. 2023;2673:431-452. doi: 10.1007/978-1-0716-3239-0_29. Methods Mol Biol. 2023. PMID: 37258931

5

Helminth-derived biomolecules as potential therapeutics against ulcerative colitis.

Chakraborty A, Bayry J, Mukherjee S. Chakraborty A, et al. Among authors: mukherjee s. Immunotherapy. 2024;16(10):635-640. doi: 10.1080/1750743X.2024.2360382. Epub 2024 Jun 18. Immunotherapy. 2024. PMID: 38888436 No abstract available.

6

In-silico evidences on filarial cystatin as a putative ligand of human TLR4.

Das NC, Sen Gupta PS, Biswal S, Patra R, Rana MK, Mukherjee S. Das NC, et al. Among authors: mukherjee s. J Biomol Struct Dyn. 2022;40(19):8808-8824. doi: 10.1080/07391102.2021.1918252. Epub 2021 May 6. J Biomol Struct Dyn. 2022. PMID: 33955317

7

In Silico Analyses on the Comparative Potential of Therapeutic Human Monoclonal Antibodies Against Newly Emerged SARS-CoV-2 Variants Bearing Mutant Spike Protein.

Das NC, Chakraborty P, Bayry J, Mukherjee S. Das NC, et al. Among authors: mukherjee s. Front Immunol. 2022 Jan 10;12:782506. doi: 10.3389/fimmu.2021.782506. eCollection 2021. Front Immunol. 2022. PMID: 35082779 Free PMC article.

8

Designing AbhiSCoVac - A single potential vaccine for all 'corona culprits': Immunoinformatics and immune simulation approaches.

Choudhury A, Sen Gupta PS, Panda SK, Rana MK, Mukherjee S. Choudhury A, et al. Among authors: mukherjee s. J Mol Liq. 2022 Apr 1;351:118633. doi: 10.1016/j.molliq.2022.118633. Epub 2022 Jan 31. J Mol Liq. 2022. PMID: 35125571 Free PMC article.

9

Comparative Binding Ability of Human Monoclonal Antibodies against Omicron Variants of SARS-CoV-2: An In Silico Investigation.

Das NC, Chakraborty P, Bayry J, Mukherjee S. Das NC, et al. Among authors: mukherjee s. Antibodies (Basel). 2023 Feb 23;12(1):17. doi: 10.3390/antib12010017. Antibodies (Basel). 2023. PMID: 36975364 Free PMC article.

10

Programmed cell death pathways as targets for developing antifilarial drugs: Lessons from the recent findings.

Das NC, Chakraborty P, Nandy S, Dey A, Malik T, Mukherjee S. Das NC, et al. Among authors: mukherjee s. J Cell Mol Med. 2023 Oct;27(19):2819-2840. doi: 10.1111/jcmm.17913. Epub 2023 Aug 22. J Cell Mol Med. 2023. PMID: 37605891 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,877 results

Search Page

Filters